[1] Jagannathan V, Robinson-Rechavi M.The challenge of modeling nuclear receptor regulatory networks in mammalian cells[J]. Mol Cell Endocrinol, 2011, 334(1/2): 91-97. [2] 李桃园,章国良. 代谢性核受体功能及转录活性调控机制的研究进展[J]. 中国临床药理学杂志, 2009, 25(4): 346-349. [3] Escriva H, Delaunary F, Laudet V.Ligand binding and nuclear receptor evolution[J]. Bio Essays, 2000, 22(80): 717-727. [4] 苏静华, 孙建国, 王广基. 药物诱导CYP450的体外检测方法研究进展[J]. 中国临床药理学与治疗学, 2010, 15(8): 954-960. [5] Aranda A, Pascual A.Nuclear hormone receptors and gene expression[J]. Physiol Rev, 2001, 81(3): 1269-1304. [6] 刘彦锋, 李红星, 赵长琦, 等. 核受体在药物代谢中的作用[J]. 食品与药品, 2008, 10(3): 64-68. [7] Kobayashi K, Sueyoshi T, Inoue K, et al.Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells[J]. Mol Pharmacol, 2003, 64(5): 1069-1075. [8] Simonsson US, Lindell M, Raffalli-Mathied F, et al.In vivo and mechanistic evidence of nuclear receptor CAR induction by artemisinin[J]. Eur J Clin invest, 2006, 36(9): 647-653. [9] Kakizaki S, Karami S, Neqishi M.Retinoic acids repress constitutive active receptor-mediated induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene of the CYP2B10 gene in mouse primary hepatocytes[J]. Drug Metab Dispos, 2002, 30(2): 208-211. [10] Huang W, Zhang J, Chua SS, et al.Induction of bilirubin clearance by the constitutive androstane receptor (CAR)[J]. Proc Natl Acad Sci USA, 2003, 100(7): 4156-4161. [11] Pustylnyak V, Pivovarova E,Slynko N, et al.Species-specific induction of CYP2B by 2,4,6-tryphenyldioxane-1,3(TPD)[J]. Life Sci, 2009, 86(23/24/25/26): 815-821. [12] Yuan F, Chen J, Wu WJ, et al.Effects of matrine and oxymatrine on catalytic activity of cytochrome P450s in rats[J]. Basic Clin Pharmacol Toxicol, 2010, 107(5): 906-913. [13] Zhou SF.Drug behave as substrates., inhibitors and inducers of human cytochrome P450 3A4[J]. Curr Drug Metab, 2008, 9(4): 310-322. [14] Luo G, Cunningham M, Kim S, et al.CYP3A4 induction by drugs:correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes[J]. Drug Metab Dispos, 2002, 30(7): 795-804. [15] Yang J, Luan X, Gui H.Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes[J]. Br J Pharmacol, 2011, 162(2): 441-451. [16] Smith NF, Mani S, Schuetz EG, et al.Induction of CYP3A4 by vinblastine: role of the nuclear receptor NR1I2[J]. Ann Pharmacother, 2010, 44(11): 1709-1717. [17] Orans J, Teotico DG, Redinbo MR.The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges[J]. Mol Endocrinol, 2005, 19(12): 2891-2900. [18] Ding X, Staudinger JL.Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway[J]. J Pharmacol Exp Ther, 2005, 312(2): 849-856. [19] Gupta D, Venkatesh MK, Wang H, et al.Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer[J]. Clin Cancer Res, 2008, 14(17): 5332-5340. [20] Takeshita A, Taguchi M, Koibuchi N, et al.Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics[J]. Biol Chem, 2002, 277(36): 32453-32458. [21] Wang H, Huang H, Li H.Activated pregnenolone X-receptor is a target for ketoconazole and its analogs[J]. Clin Cancer Res, 2007,13(8): 2488-2495. [22] Zhou C, Poulton EJ, Grun F.The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor[J]. Mol Pharmacol, 2007, 71(1): 220-229. [23] Wang H, Faucette SR, Gilbert D, et al.Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes[J]. Drug Metab Dospos, 2003, 31(5): 620-630. [24] Pascussi JM, Gerbal-Chaloin S, Fabre JM, et al.Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation[J]. Mol Pharmacol, 2000, 58(6): 1441-1450. [25] Cooper BW, Cho TM, Thompson PM.Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression[J]. Toxicol Sci, 2008, 103(2): 267-277. [26] Barouki R, Coumoul X, Fernandez-Salguero PM.The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein[J]. FEBS Lett, 2007, 581(19): 3608-3615. [27] Swanson HI.DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation[J]. Chem Biol Interact, 2002, 141(1/2): 63-76. [28] Korashy HM, Shayeganpour A, Brocks DR, et al.Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines[J]. Toxicol Sci, 2007, 97(1): 32-43. [29] Anwar-Mohamed A, EI-Kadi AO.Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium[J]. Drug Metab Dispos, 2008, 36(9): 1819-1827. |